Dr. Javed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-9060
Education & Training
- Yale-New Haven Medical CenterResidency, Neurology, 2001 - 2004
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2000 - 2003
- Southern Illinois University School of MedicineClass of 2000
Certifications & Licensure
- IL State Medical License 2000 - 2026
- IN State Medical License 2011 - 2015
- CT State Medical License 2003 - 2004
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis Start of enrollment: 2011 Jun 01
- Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses Start of enrollment: 2016 Dec 20
Publications & Presentations
PubMed
- 40 citationsRepopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.Wendy Gilmore, Brett T. Lund, Peili Li, Alexander M Levy, Eve E. Kelland
Journal of Neuroinflammation. 2020-06-15 - 119 citationsChapter 35 – Acute disseminated encephalomyelitisAdil Javed, Omar Khan
Handbook of Clinical Neurology. 2014-12-31 - 29 citationsCross-Immunoreactivity between Bacterial Aquaporin-Z and Human Aquaporin-4: Potential Relevance to Neuromyelitis OpticaZhihua Ren, Yan Wang, Tao Duan, Jilpa Patel, Thomas Liggett
Journal of Immunology. 2012-11-01
Press Mentions
- 203 UChicago Medicine Doctors Named to 2022 Top Docs ListJanuary 21st, 2022
- New UPLIZNA® (Inebilizumab-Cdon) Data in People with Neuromyelitis Optica Spectrum Disorder (NMOSD) to Be Presented at the American Academy of Neurology’s 73rd Annual MeetingApril 5th, 2021
- New Multiple Sclerosis Treatment Offers Breakthrough for PatientsApril 20th, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: